Journal of Virology · 1999 · 78 citations · 38 references
Life SciencesBiotechnologyMolecular BiologyGene TherapyMolecular VirologyVirologyAntiretroviral TherapyAntiviral ImmunityAntiviral TherapyGene Delivery VectorsViral Gene ExpressionViral TranscriptionGene Therapy For ImmunodeficiencyGene Therapy VectorsHiv InfectiousnessLentiviral Vector TransductionLentiviral VectorsRetroviral Vector TransductionViral Expression VectorsViral Vectors
Recently, gene therapy vectors based upon the human immunodeficiency virus type 1 (HIV-1) genome have been developed. Here, we create an HIV-1 vector which is defective for all HIV-1 genes, but which maintains cis-acting elements required for efficient packaging, infection, and expression. In T cells transduced by this vector, vector expression is low but efficiently induced following HIV-1 infection. Remarkably, although the HIV-1 vector does not contain specific anti-HIV-1 therapeutic genes, the presence of the vector alone is sufficient to inhibit the spread of HIV-1 infection. The mechanism of inhibition is likely to be at the level of competition for limiting substrates required for either efficient packaging or reverse transcription, thereby selecting against propagation of wild-type HIV-1. These results provide proof of a concept for potential application of a novel HIV-1 vector in HIV-1 disease.
38
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
Luigi Naldini, Ulrike Blömer, Philippe Gallay et al. · Science · 1996 · 4.9K citations
Akio Adachi, Howard E. Gendelman, Scott Koenig et al. · Journal of Virology · 1986 · 2.9K citations · Full text
Gene therapy - promises, problems and prospects
Inder M. Verma, Nikunj V. Somia · Nature · 1997 · 1.7K citations
Luigi Naldini, Ulrike Blömer, Fred H. Gage et al. · Proceedings of the National Academy of Sciences · 1996 · 1.5K citations · Full text